Iveric's Zimura Succeeds In Dry AMD Study

Stock Sees Three-Day Gain Of 283%

 
• By Kevin Grogan
Eyes
The eyes have it for Iveric • Source: Shutterstock

More from Sensory

More from Therapeutic Category